SUMMARY Orbital liposarcoma is a rare and usually unsuspected neoplasm. Over a five-year period three female patients aged 22, 71, and 77 years presented with primary myxoid liposarcoma of the orbit. The management of one patient was complicated by a history of orbital decompression for suspected thyroid eye disease. The tumour infiltrates locally beyond a deceptive pseudocapsule, and surgery has to be radical to be effective.
The orbit is a rare site for primary liposarcoma,' a tumour which usually originates in deep connective tissue planes and is most common in the thigh and retroperitoneum. Only 10 orbital cases have been reported in detail so far. Four were fatal and six survived to the date of reporting.
Three patients with differing clinical features of myxoid orbital liposarcoma presented to the Orbital Clinic at Moorfields Eye Hospital during the last five years. Their cases illustrate the difficulties which may be experienced in establishing both the diagnosis and the optimum treatment of this tumour. The rationale for surgical excision is discussed in relation to the histological type and the results of studies of systemic liposarcoma.
Patients and methods CASE 1 Two years prior to presentation at this clinic a 22-year-old woman developed a painful right proptosis of fairly rapid onset. Myxoedema was diagnosed at the time, and she was treated with thyroxine and systemic steroid for presumed thyroid eye disease. There was no further deterioration during treatment.
Five months later the affected orbit was surgically decompressed into the ethmoid and maxillary sinuses, and after temporary improvement the right eye again became progressively proptosed.
When she was first seen in this clinic the visual acuities were 6/6 in both eyes. The visual acuities were 6/9 in both eyes with full fields to confrontation. A smooth, bluish swelling was seen below the right lower lid (Fig. 2) , and a rubbery, non-tender mass measuring 15 by 30 mm could be palpated on the right orbital floor. There was 3 mm of right proptosis and 2 mm of upward displacement of the right globe, with dilated conjunctival vessels. The ocular movements were full, and there was no relative afferent pupillary defect. Both optic discs were normal. Radiographs showed no abnormality, but computerised tomography revealed an indistinct opaque mass on the floor of the right orbit. Anterior orbitotomy through the lower eyelid revealed an enormous gelatinous mass extending to the orbital apex and attached to the inferior oblique muscle and optic nerve. Subtotal excision was performed.
Histopathology showed a myxoid liposarcoma with delicate vascular channels, characteristic lipoblasts, very few mitoses, and some giant and pleomorphic cells (Fig. 3 discomfort with enlargement of the tumour. Nuclear magnetic resonance imaging revealed high signal intensity on 17 weighted spin echo sequences (Fig. 6) 
CONCLUSIONS
Orbital liposarcoma is a rare tumour which presents difficulties with clinical and histopathological diagnosis. The paucity of data on treatment for a neoplasm that is surprisingly aggressive leaves the clinician with a therapeutic dilemma. The management decision should be clarified by careful determination of the histological subtype, which is of the utmost importance in predicting the prognosis.
The aggressive pleomorphic and round cell types require radical surgery in all cases. In our opinion the commoner myxoid types necessitate exenteration or midfacial resection as a life-saving procedure in a young person. In elderly patients there may be a satisfactory, though probably temporary, response to local resection. Radical surgery should be performed if there is continued growth with increasing discomfort. Radiotherapy is considered to be relatively ineffective in the treatment of this tumour. 18
